Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,243 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

NCT00446862

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Optimum Insufflation Capacity in NMD

NCT01981915

Conditions
Central Nervous System Diseases, Chronic Respiratory Insufficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • University of Essen, Children's Hospital, Dep. of Pediatric Pulmonology Essen, North Rhine-Westphalia, Germany
View Trial Details
Completed

Tadalafil in Becker Muscular Dystrophy

NCT01070511

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +8 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View Trial Details
Completed

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

NCT00823368

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

NCT01325220

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 28 locations
View Trial Details
Completed

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

NCT00892580

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome

NCT01282268

Conditions
Autism Spectrum Disorder, Child Development Disorders, Pervasive, Chromosome Disorders, +14 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Research Administration Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 24 locations
View Trial Details

Related conditions